|
Home > Software News:
|
Watch News Feed
Bestsellers Software
|
(I-SoftwareNews.Com, August 27, 2018 ) Industry Outlook and Trend Analysis
The Molecular Cytogenetics Market was worth USD 1.46 billion in 2014 and is expected to reach approximately USD 3.59 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 10.54% during the forecast period. Cytogenetic analysis was earlier restricted to examination of cellular aspects that covered diagnosis of genomic distortions and study of chromosomal structure in heredity conditions. In the present situation, cytogenetic analysis goes past simple investigation of chromosomal status of genome. This has quickened the study of chromosomal changes that are associated with sickness pathogenesis, three-dimensional association of the human genome, and nature of acquired syndromes.
Request for Free Sample@ https://www.qurateresearch.com/report/sample/ICT/QBI-CMR-ICT-54421
Application Outlook and Trend Analysis
A detailed understanding of genomes is vital in accomplishing various objectives of cancer management: fast and precise diagnosis, recurrence risk estimation, therapeutic strategies, and survival prediction. Effective and high usage of molecular cytogenetic methods for in-depth analysis of cancer has empowered oncology to develop as the biggest application section. Pharmacotherapies and customized treatment choices are perceived as the two most imperative methodologies for accomplishing enhanced treatment results.
Product Outlook and Trend Analysis
The molecular cytogenetics market offers a wide scope of products, for example, consumables, instruments/equipment, and software and services. Progressions in molecular biology methods have additionally impelled the improvement of related reagents, software, consumables, and kits. Rising usage of media and reagents while performing cytogenetic analysis has rendered consumables as the biggest section. Consumables help with increasing precise and reproducible outcomes in standard and also advanced clinical cytogenetic protocols.
End User Outlook and Trend Analysis
Clinical and research laboratories ruled the market in 2016. This is significantly because of developing usage of cytogenetic methods in clinical determination. Progressing research relating to pathways underlying different chromosomal infections has empowered this section to accomplish the biggest share.
Technology Outlook and Trend Analysis
Accessibility, cost, turnaround time, and specificity are key factors that play a critical part in the selection of cytogenetic methods. In the current situation, CGH and FISH strategies are adopted extensively over different applications, for example, research activities, medicine development, and diagnostics.
Regional Outlook and Trend Analysis
North America represented the biggest share in 2016 primarily because of the existence of major entities, for example, Agilent Technologies, Inc. In addition, existence of effective regulatory structure for the regulation of genetic tests has altogether impelled the regional market. Asia Pacific is anticipated to rise as the quickest developing provincial market throughout the figure time frame.
Competitive Insights
The leading players in the market are Bio-Rad Laboratories, Bio View Ltd, Agilent Technologies, Quest Diagnostics, Oxford Gene Technology, Illumina, Applied Spectral Imaging Inc, Danaher Corporation, PerkinElmer, Roche Holding AG and CytoTest. Understanding the developing demand for cytogenetic analysis among the consumers and manufacturers are making beneficial investments to widen their product portfolio. They are likewise captivating in commonly advantageous organizations with labs and research foundations, which thus, boost income generation for these organizations.
Enquiry About Report@ https://www.qurateresearch.com/report/enquiry/ICT/QBI-CMR-ICT-54421
The Molecular Cytogenetics Market is segmented as follows-
By Application:
Oncology
Genetic Disorders
Personalized Medicine
Other Applications
By Product:
Consumables
Instruments
Software & Services
By End User:
Hospitals & Pathology Laboratories
Pharmaceutical and Biotechnology Companies
Clinical & Research Laboratories
Academic Research Institutes
Other End-use
By Technology:
Fluorescence in Situ Hybridization (FISH)
Karyotyping
Comparative Genomic Hybridization
Immunohistochemistry
Other Techniques
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Russia
Italy
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Rest of Asia-Pacific
South America
Brazil
Argentina
Columbia
South Africa
Rest of South America
Middle East and Africa
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Rest of MEA
Some of the key questions answered by the report are:
What was the market size in 2014 and forecast from 2015 to 2023?
What will be the industry market growth from 2015 to 2023?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Click Link to Buy Now@ https://www.qurateresearch.com/report/buy/ICT/QBI-CMR-ICT-54421/
Qurate Business Intelligence
Nehal Chinoy
+919881074592
nehal@qurateresearch.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
|
I-SoftwareNews.Com Sponsors
|
|
|
|
|
